Shockwave can be a useful non-invasive option for selected persistent tendon and heel problems. Choosing the right condition, device and rehabilitation plan matters more than treating every painful area with the same approach.
Outside the body
A handheld applicator delivers mechanical pulses through the skin, usually with contact gel. It is not an electrical shock. [6]
Not all devices are alike
Focused shockwaves and radial pressure waves differ. Device, energy and target depth matter; evidence from one protocol is not automatically evidence for another. [7]
A planned course, then review
Agree the goal, expected number of sessions, cost, alternatives and how the response will be assessed. Improvement is not guaranteed.
Where are the clearest opportunities?
Plantar heel pain
A 2024 review of 16 trials involving 1,121 people with plantar fasciitis found better pain and foot-function results with shockwave than corticosteroid injections at three and six months. This supports discussing it as an option, not claiming superiority over every treatment or guaranteed individual success. [1]
Calcific shoulder tendinopathy
The 2025 rotator-cuff guideline permits shockwave to help pain and disability in adults with calcific tendinopathy. The same guideline recommends against it for rotator-cuff tendinopathy without calcification. These are different situations, not one generic shoulder treatment. [2]
Achilles pain needs a separate discussion
For insertional Achilles pain, at the heel attachment, a 2025 trial of 76 adults found no evidence of added benefit over sham when three radial treatments were combined with the same exercise and education, at six or twelve weeks. This does not establish equivalence, but it does mean an added benefit should not be promised. [3]
A 2026 systematic review also found no statistically significant pain or disability advantage for midportion Achilles tendinopathy in its pooled comparisons; certainty varied. Findings should not be transferred indiscriminately between insertional and midportion pain. Treatment choices should account for rehabilitation already tried, individual goals, costs and uncertainty. [4]
How might it work?
Proposed mechanisms include changes in pain sensitivity and tissue responses to mechanical stimulation. The exact clinical mechanism is not settled. Laboratory explanations or an immediate change in pain do not prove that a tendon has healed, that calcium deposits will disappear or that everyone will benefit. [6]
Assess first
Confirm the likely diagnosis and whether the proposed device and technique fit it.
Adjust to tolerance
The procedure can be uncomfortable. Tell the clinician so treatment can be adjusted or stopped. [6]
Keep rehabilitation central
Agree activity and exercise advice and reassess progress. Less pain immediately after treatment is not clearance for unrestricted loading.
Safety, contraindications and precautions
Potential side effects include local pain, redness, bruising, swelling, nerve irritation and headache. A 2025 expert consensus identifies a small potential risk of tendon rupture; this is safety guidance, not proof of treatment benefit. [5]
ISMST lists a tumour, fetus or pacemaker/defibrillator in the treatment field as contraindications to radial or low-energy focused treatment. High-energy focused treatment has additional restrictions, including lung or central nervous tissue in the field and significant coagulation disorders. These restrictions depend on location and technique, not simply a diagnosis anywhere in the body. [7]
Tell your clinician about pregnancy, implanted devices, bleeding disorders, blood-thinning medicines, recent steroid injections and current medicines before treatment. Do not stop prescribed medication on your own to receive shockwave. The 2025 consensus did not resolve all medication-related precautions, so individual assessment is important. [5]
References
Recent clinical research and guidelines inform benefit claims. Expert consensus and patient leaflets below are identified separately as practical and safety guidance.
- Cortés-Pérez I, et al. Efficacy of extracorporeal shockwave therapy, compared to corticosteroid injections, on pain, plantar fascia thickness and foot function in patients with plantar fasciitis: a systematic review and meta-analysis. Clinical Rehabilitation. 2024;38(8). Review abstract.
- Desmeules F, et al. Rotator Cuff Tendinopathy Diagnosis, Nonsurgical Medical Care, and Rehabilitation: A Clinical Practice Guideline. JOSPT. 2025;55(4). Recommendations 29–30. Guideline; full guideline PDF.
- Alsulaimani B, et al. Does shockwave therapy lead to better pain and function than sham over 12 weeks in people with insertional Achilles tendinopathy? A randomised controlled trial. Clinical Rehabilitation. 2025;39(2):174–186. Trial; university abstract.
- Shockwave Therapy for Midportion and Insertional Achilles Tendinopathy: A Nail in the Coffin? A Systematic Review With Meta-Analysis. JOSPT. 2026;56(5):282–299. Review abstract.
- Recommendations for use of extracorporeal shockwave therapy in sports medicine: an international modified Delphi study. British Journal of Sports Medicine. 2025. Expert consensus, supplementary safety and practice guidance. Consensus paper.
- Royal National Orthopaedic Hospital NHS Trust. A Patient’s Guide to Radial Extracorporeal Shockwave Therapy. Supplementary procedure and safety information, not an efficacy review. Patient leaflet.
- International Society for Medical Shockwave and Regenerative Treatment. Indications and contraindications. Supplementary society guidance; not a guarantee of efficacy for listed conditions. Society guidance.
Prepared November 2026. General information, not an individual diagnosis or treatment prescription.